Boston, MA -- (SBWIRE) -- 05/09/2017 -- Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021

The global metabolomics market is projected to reach USD 2.39 billion by 2021, at a CAGR of 14.6% during the forecast period of 2016 to 2021. The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.

In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Based on product and service, this market is further segmented into two major segments—metabolomics instruments and metabolomics bioinformatics tools & services. Based on metabolomics instruments, the market is further segmented into detection tools and separation tools. The separation tools segment commanded the largest share in the global metabolomics instruments market in 2015. The large share of this segment can be attributed to the ease of separation, characterization of metabolites, and quantitation of chemical compounds achieved by separation tools such as UPLC.

Get More Details on this Report and a Full Table of Contents at Metabolomics Market - Forecast to 2021

Based on application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.

In 2015, North America commanded the largest share of the metabolomics market, followed by Europe. The U.S. is the prime market for metabolomics due to the rising acceptance of personalized medicines and growing focus of stakeholders on research projects involving metabolites, amino acid composition, and associated biomolecules in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Major players in the global metabolomics market are Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.).

Research Coverage

-Detailed insights on all the submarkets, based on metabolomics instruments (Gas Chromatography, Capillary Electrophoresis, High-performance Liquid Chromatography, Ultra-performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, and Surface-based Mass Analysis), this can help market players to identify high growth segments in the metabolomics market.

-The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.

-Key insights and market sizing for the different end users of the metabolomics market namely, hospitals, laboratories, academic institutes, biotechnology firms, clinical research laboratories, and other end users.

-Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product & service, technology, application, and indication areas; the market size numbers provided in the report will also enable players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.

-It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:

-Market Penetration: Comprehensive information on the product portfolios offered by top players in the metabolomics market. The report analyzes the market by product & service, application, and indication

-Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the metabolomics market

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Biotechnology research reports at Fast Market Research

You may also be interested in these related reports:
-Bioinformatics Market - Global Forecast to 2021
-Global In Vitro Toxicology Testing Market - Forecast to 2021
-Cancer/Tumor Profiling Market - Forecast to 2021
-Asia-Pacific Cardiac Rhythm Management (CRM) Procedures Outlook to 2021
-EU5 Peripheral Vascular Procedures Outlook to 2021